new medicines

Skin conditions

Nemolizumab approved for prurigo nodularis and atopic dermatitis

Nemolizumab (Nemluvio, Galderma) has been approved by the MHRA for the treatment of two skins conditions.

18 Feb 2025 , 1 Min Article

2018 pill_s.jpg

Key 2018 practice developments

This CPD module provides an overview of some of the major developments in pharmacy practice during 2018.

14 Dec 2018 , 900 Min Module

2017 review_s.jpg

Key practice developments of 2017

This CPD module provides an overview of key practice developments of 2017.

13 Dec 2017 , 900 Min Module

Change privacy settings